Conditions
Conditions Treated by GLP-1 Medications
Evidence-based guides on how GLP-1 medications treat 32 conditions — from type 2 diabetes to PCOS to cardiovascular risk reduction.
metabolic
Type 2 Diabetes
Type 2 diabetes is the primary FDA-approved indication for several GLP-1 medications including semaglutide (Ozempic), du...
Insulin Resistance
Insulin resistance is the precursor to type 2 diabetes and a key driver of weight gain, fatigue, and metabolic dysfuncti...
Metabolic Syndrome
Metabolic syndrome—a cluster of conditions including high blood pressure, high blood sugar, excess body fat, and abnorma...
NAFLD
NAFLD is the most common chronic liver condition, affecting 25% of adults. It's strongly associated with obesity and ins...
Prediabetes
Prediabetes (HbA1c 5.7-6.4%) affects 88 million Americans and often progresses to type 2 diabetes. GLP-1 medications can...
Chronic Inflammation
Chronic low-grade inflammation drives metabolic disease and accelerates aging. GLP-1 medications have potent anti-inflam...
Gout
Gout—a painful form of inflammatory arthritis—is strongly associated with obesity and metabolic syndrome. Weight loss fr...
NASH
NASH is the inflammatory, progressive form of NAFLD that can lead to cirrhosis. GLP-1 medications are becoming a corners...
GERD
Obesity is a major risk factor for GERD. Weight loss from GLP-1s often dramatically improves reflux symptoms....
weight
Obesity
Obesity (BMI ≥30) is now recognized as a chronic disease with FDA-approved GLP-1 treatments including semaglutide (Wegov...
Sleep Apnea
Obstructive sleep apnea affects 20-40% of obese adults and significantly increases cardiovascular risk. Weight loss from...
Post-Bariatric Surgery
Some patients experience weight regain after bariatric surgery. GLP-1 medications can help achieve additional weight los...
Urinary Incontinence
Excess weight increases pressure on the bladder and pelvic floor, causing stress incontinence. Weight loss from GLP-1s o...
Cancer Risk Reduction
Obesity is linked to 13 types of cancer. Weight loss from GLP-1s may reduce cancer risk, though direct cancer prevention...
hormonal
PCOS (Polycystic Ovary Syndrome)
PCOS affects 1 in 10 women and is frequently associated with insulin resistance and weight gain. GLP-1 medications offer...
Menopause-Related Weight Gain
Hormonal changes during menopause often cause weight gain, particularly around the midsection. GLP-1 medications effecti...
Thyroid-Related Weight Gain
Hypothyroidism and subclinical thyroid dysfunction can cause weight gain and make weight loss difficult. GLP-1s can help...
Infertility
Obesity is a leading cause of infertility in both men and women. Weight loss from GLP-1s can restore fertility in many c...
cardiovascular
Cardiovascular Risk
GLP-1 medications provide powerful cardiovascular protection, reducing major adverse cardiovascular events by 20-26% in ...
Hypertension
High blood pressure is common with obesity and metabolic disease. GLP-1 medications typically reduce blood pressure 5-10...
Dyslipidemia
Abnormal cholesterol and triglycerides often accompany obesity. GLP-1 medications significantly improve lipid profiles b...
mental-health
Binge Eating Disorder
Binge eating disorder (BED) is the most common eating disorder, often co-occurring with obesity. GLP-1 medications can s...
Emotional Eating
Emotional eating—using food to cope with stress, sadness, or boredom—affects millions. GLP-1 medications can break the c...
Food Addiction
Food addiction—compulsive overeating despite negative consequences—affects millions. GLP-1 medications can reduce the bi...
Depression
Obesity and depression frequently co-occur, each worsening the other. GLP-1 medications may improve mood through weight ...
aging
Age-Related Metabolic Decline
Metabolic rate naturally declines with age, making weight management increasingly difficult. GLP-1 medications effective...
Knee Osteoarthritis
Knee osteoarthritis is strongly linked to obesity, with each pound of body weight adding 4 pounds of pressure to the kne...
Sarcopenia
Age-related muscle loss affects 10% of adults over 50. GLP-1 weight loss must be carefully managed to avoid accelerating...
Osteoporosis
Rapid weight loss can affect bone density. GLP-1 users with osteoporosis need careful monitoring and bone-supporting str...
aesthetic
Cellulite
Cellulite affects 85-95% of women and is influenced by genetics, hormones, and body composition. Weight loss from GLP-1s...
Stretch Marks
Rapid weight changes can cause stretch marks. While GLP-1s cause weight loss, managing skin health during the process is...